Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9492682
APP PUB NO 20130190715A1
SERIAL NO

13619983

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure is directed to the use of sequentially applied topical therapy with a lower dosage strength imiquimod composition and photodynamic therapy for treating actinic keratosis, wherein the photodynamic therapy is administered subsequent to the topical therapy with the imiquimod composition. In some embodiments, the imiquimod composition comprises from about 1% (w/w) to about 4.25% (w/w) imiquimod.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDICIS PHARMACEUTICAL CORPORATION7720 NORTH DOBSON ROAD SCOTTSDALE AS 85256

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cohen, Joel L Denver, US 1 2
Gold, Michael H Nashville, US 1 2
Meng, Tze-Chiang Lino Lakes, US 20 207
Munavalli, Girish S Charlotte, US 1 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 15, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00